[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_19950 

# __Lack of effective pharmaceutical interventions for new strains of pandemics__

## Articles mentionning the risk

* [Kumar_role_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_680.md)

## Mitigations of this risk

* [Investing in research and development of rapid response vaccines and antiviral drugs](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_21928.md)

## Name of the risk

Delayed response and ineffective protection against new strains of pandemics

## People affected by this risk

* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_173.md)
* [Public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Stakeholders who can mitigate this risk

* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_173.md)
* [Public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Medical research and development for rapid response vaccines and antiviral drugs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_22258.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

